Muir-Torre syndrome

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 12, 2014, Pages 1685-1689

  Bhaijee, Feriyl ^a   Brown, Alexandra S ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETICS; HUMAN; MUIR-TORRE SYNDROME;

HUMANS; MUIR-TORRE SYNDROME;

EID: 84914695679     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0301-RS     Document Type: Article

References (36)

1. Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthoma of the face. Br J Surg. 1967;54(3):191-195.
2. Torre D. Multiple sebaceous adenomas. Arch Dermatol. 1968;98(5):549-551.
3. Navi D, Wadhera A, Fung MA, Fazel N. Muir-Torre syndrome. Dermatol Online J. 2006;12(5):4.
4. Hare HH, Mahendraker N, Sarwate S, Tangella K. Muir-Torre syndrome: rare but important disorder. Cutis. 2008;82(4):252-256.
5. Barana D, van der Klift H, Wijnen J, et al. Spectrum of genetic alterations in Muir-Torre syndrome is the same as in HNPCC. Am J Med Genet A. 2004;125A(3):318-319.
6. Ponti G, Losi L, Pedroni M, et al. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. J Invest Dermatol. 2006;126(10):2302-2307.
7. Pettey AA, Walsh JS. Muir-Torre syndrome: a case report and review of the literature. Cutis. 2005;75(3):149-155.
8. Akhtar S, Oza K, Khan S, et al. Muir-Torre syndrome: case report of a patient with concurrent jejuna and ureteral cancer and a review of the literature. J Am Acad Dermatol. 1999;41(5, pt 1):681-686.
9. Finan MC, Connolly SM. Sebaceous gland tumors and systemic disease: a clinicopathologic analysis. Medicine (Baltimore). 1984;63:232-242.
10. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991;90:606-613.
11. Singh RS, Grayson W, Redston M, et al. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol. 2008;32(6):932-942.
12. Ponti G, Longo C. Microsatellite instability and mismatch repair protein expression in sebaceous tumors, keratocanthoma, and basal cell carcinomas with sebaceous differentiation in Muir-Torre syndrome. J Am Acad Dermatol. 2013;68(3):509-510.
13. Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. 2005;6(12):980-987.
14. Castori M, Morrone A, Kanitakis J, Grammatico P. Genetic skin diseases predisposing to basal cell carcinoma. Eur J Dermatol. 2012;22(3):299-309.
15. Alsaad KO, Obaidat NA, Ghazarian D. Skin adnexal neoplasms-part 1: An approach to tumours of the pilosebaceous unit. J Clin Pathol. 2007;60(2):129-144.
16. Misago N, Mihara I, Ansai S, et al. Sebaceoma and related neoplasms with sebaceous differentiation: a clinicopathologic study of 30 cases. Am J Dermatopathol. 2002;24(4):294-304.
17. Pereira PR, Odashiro AN, Rodrigues-Reyes AA, et al. Histopathological review of sebaceous carcinoma of the eyelid. J Cutan Pathol. 2005;32(7):496-501.
18. Bayer-Garner IB, Givens V, Smoller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol. 1999;21(5):426-431.
19. Ansai S, Mitsuhashi Y, Kondo S, et al. Immunohistochemical differentiation of extra-ocular sebaceous carcinoma from other skin cancers. J Dermatol. 2004;31(12):998-1008.
20. Abbott JJ, Hernandez-Rios P, Amirkhan RH, Hoang MP. Cystic sebaceous neoplasms in Muir-Torre syndrome. Arch Pathol Lab Med. 2003;127(5):614-617.
21. Rutten A, Burgdorf W, Hugel H, et al. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study. Am J Dermatopathol. 1999;21(5):405-413.
22. Orta L, Klimstra DS, Qin J, et al. Toward identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics. Am J Surg Pathol. 2009;33(6):934-944.
23. Shia j, Ellis NA, Paty PB, et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol. 2003;27(11):1407-1417.
24. Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathologic identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158(2):527-535.
25. Honchel R, Halling KC, Schaid DJ, Pittelkow M, Thibodeau SN. Microsatellite instability in Muir-Torre syndrome. Cancer Res. 1994;54(5):1159-1163.
26. Lee BA, Yu L, Ma L, Lind AC, Lu D. Sebaceous neoplasms with mismatch repair protein expressions and the frequency of co-existing visceral tumors. J Am Acad Dermatol. 2012;67(6):1228-1234.
27. Fernandez-Flores A. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome. Am J Dermatopathol. 2012;34(4):416-422.
28. Chhibber V, Dresser K, Mahalingam M. MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome. Mod Pathol. 2008;21(2):159-164.
29. Roberts ME, Riegert-Johnson DL, Thomas BC, et al. Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms. J Genet Couns. 2013;22(3):393-405.
30. de la Chapelle A. Microsatellite instability. N Engl J Med. 2003;349(3):209-210.
31. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995;33(1):90-104.
32. Kazakov DV, Vanecek T, Zelger B, et al. Multiple (familial) trichoepitheliomas: a clinicopathologic and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients. Am J Dermatopathol. 2011;33(3):251-265.
33. Go JW, Kim SH, Yi SY, Cho HK. Basal cell nevus syndrome showing several histologic types of basal cell carcinoma. Ann Dermatol. 2011;23(suppl 1):S36-S40.
34. Wee SA. Multiple eruptive keratoacanthomas, de novo. Dermatol Online J 2004;10(3):19.
35. Roach ES, Sparagana SP. Diagnosis of tuberous sclerosis complex. J Child Neurol. 2004;19(9):643-649.
36. Buitrago W, Joseph AK. Sebaceous carcinoma: the great masquerader: emerging concepts in diagnosis and treatment. Dermatol Ther. 2008;21(6):459-466.